Brief: Vista Pharmaceuticals receives warning letter from U.S. FDA
13/07/2017 10:52
July 13 (Reuters) - Vista Pharmaceuticals Ltd VIPH.BO
* Says US FDA has issued a warning letter no.320-17-40
* Says shall respond with complete details of remedial
actions to US FDA before stipulated date
* Says on account of this there is no disruption of
operations and no revenue loss is envisaged
Source text - (http://bit.ly/2uUrMm4)
Further company coverage: VIPH.BO
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Vista Pharmaceuticals
See all newsBrief: Vista Pharmaceuticals Enters Joint Venture With Pleiades Therapeutics
Brief: Vista Pharmaceuticals To Issue 48.9 Million Warrants At 12 Rupees Each
Brief: Vista Pharmaceuticals To Issue Upto 17.4 Million Shares At Rupees 12.96 Each On Preferential Basis
Brief: Vista Pharmaceuticals To Consider Proposal For Raising Funds By Way Of Issue Of Preferential Issue Of Shares
Brief: Vista Pharmaceuticals Names Dhananjaya Alli As Chairman